AMWL
American Well Corporation - Ordinary Shares - Class A

3,549
Mkt Cap
$64.34M
Volume
131,586.00
52W High
$12.95
52W Low
$3.75
PE Ratio
-0.53
AMWL Fundamentals
Price
$3.78
Prev Close
$3.93
Open
$3.97
50D MA
$5.48
Beta
1.63
Avg. Volume
94,070.17
EPS (Annual)
-$13.88
P/B
0.24
Rev/Employee
$290,038.77
Loading...
Loading...
News
all
press releases
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?
HIMS faces rising regulatory strain, margin pressure and competition despite strong revenue momentum.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Hims & Hers Scales Technology-Enabled, Vertically Integrated Care
HIMS deepens its technology-enabled care model with new offerings in GLP-1 weight loss, hormone health, and custom treatments.
Zacks·9d ago
News Placeholder
Wells Fargo & Company Issues Pessimistic Forecast for American Well (NYSE:AMWL) Stock Price
Wells Fargo & Company reduced their price objective on American Well from $12.00 to $9.00 and set an "overweight" rating for the company in a research note on Wednesday...
MarketBeat·15d ago
News Placeholder
American Well (NYSE:AMWL) Given New $6.00 Price Target at Stifel Nicolaus
Stifel Nicolaus dropped their price target on American Well from $8.00 to $6.00 and set a "hold" rating on the stock in a research report on Wednesday...
MarketBeat·15d ago
News Placeholder
Compared to Estimates, American Well (AMWL) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·16d ago
News Placeholder
American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates
American Well (AMWL) delivered earnings and revenue surprises of +4.92% and +3.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·16d ago
News Placeholder
Hims & Hers Advances AI-Powered Personalized Digital Healthcare
HIMS accelerates AI-powered care with new tech leadership, personalized treatments and a major $870 million investment push.
Zacks·30d ago
News Placeholder
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
Zacks·1mo ago
News Placeholder
Hims & Hers Expands Health Access Through Subscription Revenue Model
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
Zacks·2mo ago
News Placeholder
From Apps to Nutrition: Health & Fitness Stocks to Buy Now
UNFI, AMWL, STKL, and PTON stand out as health and fitness plays, tapping into booming demand for wellness, nutrition and digital care.
Zacks·2mo ago

Latest AMWL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.